IMR-32

Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Paola Visconti
Email: paola.visconti@hsanmartino.it

P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

This is the complete description of the cell line that you selected. By clicking on a generic term (e.g., SPECIES) you will go to the corresponding index (e.g., index of species), while by clicking on a specific term (e.g., retinoblastoma) you will go to the list of corresponding cell lines (e.g., retionoblastoma cell lines).

IMR-32 (human, Caucasian, neuroblastoma)

SPECIES: human, Caucasian
TUMOR: neuroblastoma

DSMZ catalog code: ACC 165
Morphology: fibroblast-like adherent cells growing as monolayer
Susceptibility to viruses: adenovirus 12 * Coxsackie B3 * herpes simplex * poliovirus 3 * vaccinia * vesic. stomatitis (Indiana)
Description: human neuroblastoma established from an abdominal mass (diagnosed as neuroblastoma) of a 1-year-old Caucasian boy in 1967 confirmed as human with IEF of AST, MDH, PEP B
Viruses: ELISA: reverse transcriptase negative; PCR: EBV-, HBV-, HCV-, HHV-8-, HIV-, HTLV-I/II-
Depositor: Dr. J. Wehland, GBF, Braunschweig, Germany
General Restrictions

Available in the following LABORATORY:

German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig)
80% RPMI 1640 + 20% FBS + 1x non-essential amino acids split confluent culture 1:2 every 3-5 days (trypsin should not be used, cells can be detached by tapping the flask or pipetting); seed out at ca. 0.5-1.0 x 106 cells/cm 2 at 37C with 5% CO2 about 1-2 x 106 cells/ml or 0.5 x 106 cells/cm 2; doubling time of ca. 40-50 hours; frozen with 70% medium, 20% FBS, 10% DMSO at about 2 x 106 cells/ampoule; negative in DAPI, microbiological culture, RNA hybridization assays;
Validated by: cytogenetics 1 (hyperdiploid karyotype; 49(44-51)<2n>XY, +1, +6, +12, der(1)t(1;2HSR)(p33/35;?p22)x2, der(16)t(2;16)(p21/22;q24/25); HSR regions probably represent amplification of the N-myc oncogene which maps to 2p22 involved in the t(2;16) als) * immunological analysis (cytokeratin- desmin- endothel- GFAP- neurofilament+ vimentin++) * isoenzymes (confirmed as human with IEF of AST, MDH, PEP B) * reverse transcriptase (reverse transcriptase negative)

Availability in cell line catalogues: ATCC: CCL 127, ICLC: HTL96021

Bibliographic references:

Cancer Res 1970;30:2110 - PMID: 5459762